{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:40:46Z","timestamp":1792424446328,"version":"4.5.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:00:00Z","timestamp":1792368000000},"content-version":"vor","delay-in-days":90,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100002742","name":"Banaras Hindu University","doi-asserted-by":"publisher","award":["Seed Grant (Institute of Eminence)"],"award-info":[{"award-number":["Seed Grant (Institute of Eminence)"]}],"id":[{"id":"10.13039\/501100002742","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-16217-6","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T09:55:22Z","timestamp":1784627722000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Non-invasive diagnostic evaluation of urinary exosomal let-7c cluster expression in bladder cancer using machine learning approaches"],"prefix":"10.1186","volume":"26","author":[{"given":"Sukhad","family":"Kural","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lalit","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhay Kumar","family":"Pathak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shweta","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garima","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahima","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yashasvi","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ujwal","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer","family":"Trivedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjari","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakshi","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vibhav","family":"Gautam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parimal","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,21]]},"reference":[{"key":"16217_CR1","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12967-020-02308-w","volume":"18","author":"W Fang","year":"2020","unstructured":"Fang W, Yang Z-Y, Chen T-Y, Shen X-F, Zhang C. Ethnicity and survival in bladder cancer: a population-based study based on the SEER database. J Transl Med. 2020;18:145. https:\/\/doi.org\/10.1186\/s12967-020-02308-w.","journal-title":"J Transl Med"},{"key":"16217_CR2","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.euo.2022.10.003","volume":"5","author":"N Lobo","year":"2022","unstructured":"Lobo N, Afferi L, Moschini M, Mostafid H, Porten S, Psutka SP, et al. Epidemiology, Screening, and Prevention of Bladder Cancer. Eur Urol Oncol. 2022;5:628\u201339. https:\/\/doi.org\/10.1016\/j.euo.2022.10.003.","journal-title":"Eur Urol Oncol"},{"key":"16217_CR3","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1089\/cren.2019.0140","volume":"6","author":"L Kumar","year":"2020","unstructured":"Kumar L, Arya MC. Giant Vesical Calculus with Adenocarcinoma of the Bladder: A Rare Association. J Endourol Case Rep. 2020;6:83\u20135. https:\/\/doi.org\/10.1089\/cren.2019.0140.","journal-title":"J Endourol Case Rep"},{"key":"16217_CR4","doi-asserted-by":"publisher","first-page":"4259","DOI":"10.3390\/jcm12134259","volume":"12","author":"D Jakus","year":"2023","unstructured":"Jakus D, \u0160oli\u0107 I, Juri\u0107 I, Borovac JA, \u0160itum M. The Impact of the Initial Clinical Presentation of Bladder Cancer on Histopathological and Morphological Tumor Characteristics. J Clin Med. 2023;12:4259. https:\/\/doi.org\/10.3390\/jcm12134259.","journal-title":"J Clin Med"},{"key":"16217_CR5","doi-asserted-by":"publisher","first-page":"1002301","DOI":"10.37349\/etat.2025.1002301","volume":"6","author":"D Godlewski","year":"2025","unstructured":"Godlewski D, Bartusik-Aebisher D, Czech S, Szpara J, Aebisher D. Bladder cancer biomarkers. Explor Target Anti-Tumor Ther. 2025;6:1002301. https:\/\/doi.org\/10.37349\/etat.2025.1002301.","journal-title":"Explor Target Anti-Tumor Ther"},{"key":"16217_CR6","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1245\/s10434-024-16424-0","volume":"32","author":"S Kural","year":"2025","unstructured":"Kural S, Pathak AK, Singh S, Jain G, Yadav M, Agarwal S, et al. Prospective Assessment of VI-RADS with Muscle Invasion in Urinary Bladder Cancer and Its Implication on Re-Resection\/Restaging TURBT Patients. Ann Surg Oncol. 2025;32:609\u201318. https:\/\/doi.org\/10.1245\/s10434-024-16424-0.","journal-title":"Ann Surg Oncol"},{"key":"16217_CR7","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.eururo.2024.07.027","volume":"86","author":"P Gontero","year":"2024","unstructured":"Gontero P, Birtle A, Capoun O, Comp\u00e9rat E, Dominguez-Escrig JL, Liedberg F, et al. European Association of Urology Guidelines on Non\u2013muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)\u2014A Summary of the 2024 Guidelines Update. Eur Urol. 2024;86:531\u201349. https:\/\/doi.org\/10.1016\/j.eururo.2024.07.027.","journal-title":"Eur Urol"},{"key":"16217_CR8","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.urology.2025.01.004","volume":"199","author":"R Tripathy","year":"2025","unstructured":"Tripathy R, Kumar L, Agarwal S, Thakur A, Khairnar M, Trivedi S, et al. A Comparison Between Intravesical Gemcitabine Plus Docetaxel and Intravesical Bacillus Calmette-Gu\u00e9rin in the Treatment of Nonmuscle Invasive Naive Urinary Bladder Cancer: A Systematic Review and Meta-analysis of Oncological Outcomes. Urology. 2025;199:171\u20138. https:\/\/doi.org\/10.1016\/j.urology.2025.01.004.","journal-title":"Urology"},{"key":"16217_CR9","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1016\/j.euo.2024.01.014","volume":"7","author":"R Kool","year":"2024","unstructured":"Kool R, Dragomir A, Kulkarni GS, Marcq G, Breau RH, Kim M, et al. Benefit of Neoadjuvant Cisplatin-based Chemotherapy for Invasive Bladder Cancer Patients Treated with Radiation-based Therapy in a Real-world Setting: An Inverse Probability Treatment Weighted Analysis. Eur Urol Oncol. 2024;7:1350\u20137. https:\/\/doi.org\/10.1016\/j.euo.2024.01.014.","journal-title":"Eur Urol Oncol"},{"key":"16217_CR10","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.3390\/diagnostics12112696","volume":"12","author":"C Bulai","year":"2022","unstructured":"Bulai C, Geavlete P, Ene C-V, Bulai I, Popescu R-I, Mares C, et al. Detection of Urinary Molecular Marker Test in Urothelial Cell Carcinoma: A Review of Methods and Accuracy. Diagn Basel Switz. 2022;12:2696. https:\/\/doi.org\/10.3390\/diagnostics12112696.","journal-title":"Diagn Basel Switz"},{"key":"16217_CR11","doi-asserted-by":"publisher","first-page":"100049","DOI":"10.1016\/j.vesic.2024.100049","volume":"4","author":"S Singh","year":"2024","unstructured":"Singh S, Chen CC, Kim S, Singh A, Singh G. Role of Extracellular vesicle microRNAs and RNA binding proteins on glioblastoma dynamics and therapeutics development. Extracell Vesicle. 2024;4:100049. https:\/\/doi.org\/10.1016\/j.vesic.2024.100049.","journal-title":"Extracell Vesicle"},{"key":"16217_CR12","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3390\/cancers13010084","volume":"13","author":"H Aheget","year":"2020","unstructured":"Aheget H, Mazini L, Martin F, Belqat B, Marchal JA, Benabdellah K, Exosomes. Their Role in Pathogenesis, Diagnosis and Treatment of Diseases. Cancers. 2020;13:84. https:\/\/doi.org\/10.3390\/cancers13010084.","journal-title":"Cancers"},{"key":"16217_CR13","doi-asserted-by":"publisher","first-page":"113055","DOI":"10.1016\/j.biopha.2022.113055","volume":"150","author":"X Li","year":"2022","unstructured":"Li X, Yang L. Urinary exosomes: Emerging therapy delivery tools and biomarkers for urinary system diseases. Biomed Pharmacother. 2022;150:113055. https:\/\/doi.org\/10.1016\/j.biopha.2022.113055.","journal-title":"Biomed Pharmacother"},{"key":"16217_CR14","doi-asserted-by":"publisher","first-page":"98","DOI":"10.4103\/iju.iju_442_24","volume":"41","author":"R Tripathy","year":"2025","unstructured":"Tripathy R, Kumar L, Kural S, Thakur A, Trivedi S, Sankhwar SN. The current status of miRNA in urinary bladder cancer: A minireview and strength, weakness, opportunity, and threat analysis. Indian J Urol IJU J Urol Soc India. 2025;41:98\u2013103. https:\/\/doi.org\/10.4103\/iju.iju_442_24.","journal-title":"Indian J Urol IJU J Urol Soc India"},{"key":"16217_CR15","doi-asserted-by":"publisher","first-page":"120113","DOI":"10.1016\/j.cca.2024.120113","volume":"567","author":"A Chattopadhaya","year":"2025","unstructured":"Chattopadhaya A, Kural S, Verma A, Gupta P, Tiwari H, Singh S, et al. Urinary miRNAs in bladder cancer. Clin Chim Acta. 2025;567:120113. https:\/\/doi.org\/10.1016\/j.cca.2024.120113.","journal-title":"Clin Chim Acta"},{"key":"16217_CR16","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3389\/fendo.2018.00402","volume":"9","author":"J O\u2019Brien","year":"2018","unstructured":"O\u2019Brien J, Hayder H, Zayed Y, Peng C. Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation. Front Endocrinol. 2018;9:402. https:\/\/doi.org\/10.3389\/fendo.2018.00402.","journal-title":"Front Endocrinol"},{"key":"16217_CR17","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/978-1-61779-427-8_21","volume":"822","author":"X Zhong","year":"2012","unstructured":"Zhong X, Coukos G, Zhang L. miRNAs in human cancer. Methods Mol Biol Clifton NJ. 2012;822:295\u2013306. https:\/\/doi.org\/10.1007\/978-1-61779-427-8_21.","journal-title":"Methods Mol Biol Clifton NJ"},{"key":"16217_CR18","doi-asserted-by":"publisher","first-page":"1437951","DOI":"10.3389\/fcell.2024.1437951","volume":"12","author":"L Gan","year":"2024","unstructured":"Gan L, Zheng L, Zou J, Luo P, Chen T, Zou J, et al. MicroRNA-21 in urologic cancers: from molecular mechanisms to clinical implications. Front Cell Dev Biol. 2024;12:1437951. https:\/\/doi.org\/10.3389\/fcell.2024.1437951.","journal-title":"Front Cell Dev Biol"},{"key":"16217_CR19","doi-asserted-by":"publisher","first-page":"116412","DOI":"10.1016\/j.biopha.2024.116412","volume":"174","author":"M Shen","year":"2024","unstructured":"Shen M, Chen T, Li X, Zhao S, Zhang X, Zheng L, et al. The role of miR-155 in urologic malignancies. Biomed Pharmacother. 2024;174:116412. https:\/\/doi.org\/10.1016\/j.biopha.2024.116412.","journal-title":"Biomed Pharmacother"},{"key":"16217_CR20","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1186\/s13046-019-1406-6","volume":"38","author":"C Braicu","year":"2019","unstructured":"Braicu C, Buiga R, Cojocneanu R, Buse M, Raduly L, Pop LA, et al. Connecting the dots between different networks: miRNAs associated with bladder cancer risk and progression. J Exp Clin Cancer Res. 2019;38:433. https:\/\/doi.org\/10.1186\/s13046-019-1406-6.","journal-title":"J Exp Clin Cancer Res"},{"key":"16217_CR21","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s40169-019-0240-y","volume":"8","author":"E Chirshev","year":"2019","unstructured":"Chirshev E, Oberg KC, Ioffe YJ, Unternaehrer JJ. Let-7 as biomarker, prognostic indicator, and therapy for precision medicine in cancer. Clin Transl Med. 2019;8:24. https:\/\/doi.org\/10.1186\/s40169-019-0240-y.","journal-title":"Clin Transl Med"},{"key":"16217_CR22","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.12122\/j.issn.1673-4254.2021.07.08","volume":"41","author":"Y Yao","year":"2021","unstructured":"Yao Y, Zhang C, Xiong Y, Han B, Gao X, Wang S. [miR-let-7c-5p inhibits invasion and migration of bladder cancer cells by targeting HMGA2]. Nan Fang Yi Ke Da Xue Xue Bao. 2021;41:1022\u20139. https:\/\/doi.org\/10.12122\/j.issn.1673-4254.2021.07.08.","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"16217_CR23","doi-asserted-by":"publisher","first-page":"86","DOI":"10.18632\/genesandcancer.103","volume":"7","author":"RL Vinall","year":"2016","unstructured":"Vinall RL, Tepper CG, Ripoll AAZ, Gandour-Edwards RF, Durbin-Johnson BP, Yap SA, et al. Decreased expression of let-7c is associated with non-response of muscle-invasive bladder cancer patients to neoadjuvant chemotherapy. Genes Cancer. 2016;7:86\u201397. https:\/\/doi.org\/10.18632\/genesandcancer.103.","journal-title":"Genes Cancer"},{"key":"16217_CR24","doi-asserted-by":"publisher","first-page":"403","DOI":"10.3892\/ol.2023.13989","volume":"26","author":"R Sun","year":"2023","unstructured":"Sun R, Wang C, Wang Y, Wu Y, Du P, Sun X, et al. Role of miR\u2013let\u20137c\u20135p\/c\u2013myc signaling axis in the committed differentiation of leukemic THP\u20131 cells into monocytes\/macrophages. Oncol Lett. 2023;26:403. https:\/\/doi.org\/10.3892\/ol.2023.13989.","journal-title":"Oncol Lett"},{"key":"16217_CR25","doi-asserted-by":"publisher","first-page":"2415","DOI":"10.3390\/cells10092415","volume":"10","author":"Y Ma","year":"2021","unstructured":"Ma Y, Shen N, Wicha MS, Luo M. The Roles of the Let-7 Family of MicroRNAs in the Regulation of Cancer Stemness. Cells. 2021;10:2415. https:\/\/doi.org\/10.3390\/cells10092415.","journal-title":"Cells"},{"key":"16217_CR26","doi-asserted-by":"publisher","first-page":"68627","DOI":"10.18632\/oncotarget.19800","volume":"8","author":"A Truini","year":"2017","unstructured":"Truini A, Coco S, Nadal E, Genova C, Mora M, Dal Bello MG, et al. Downregulation of miR-99a\/let-7c\/miR-125b miRNA cluster predicts clinical outcome in patients with unresected malignant pleural mesothelioma. Oncotarget. 2017;8:68627\u201340. https:\/\/doi.org\/10.18632\/oncotarget.19800.","journal-title":"Oncotarget"},{"key":"16217_CR27","doi-asserted-by":"publisher","first-page":"e1635","DOI":"10.1002\/wrna.1635","volume":"12","author":"J Eniafe","year":"2021","unstructured":"Eniafe J, Jiang S. MicroRNA-99 family in cancer and immunity. WIREs RNA. 2021;12:e1635. https:\/\/doi.org\/10.1002\/wrna.1635.","journal-title":"WIREs RNA"},{"key":"16217_CR28","doi-asserted-by":"publisher","first-page":"e19188","DOI":"10.7717\/peerj.19188","volume":"13","author":"Y Wang","year":"2025","unstructured":"Wang Y, Huang D, Li M, Yang M. MicroRNA-99 family in cancer: molecular mechanisms for clinical applications. PeerJ. 2025;13:e19188. https:\/\/doi.org\/10.7717\/peerj.19188.","journal-title":"PeerJ"},{"key":"16217_CR29","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13046-015-0167-0","volume":"34","author":"H Zhou","year":"2015","unstructured":"Zhou H, Tang K, Xiao H, Zeng J, Guan W, Guo X, et al. A panel of eight-miRNA signature as a potential biomarker for predicting survival in bladder cancer. J Exp Clin Cancer Res. 2015;34:53. https:\/\/doi.org\/10.1186\/s13046-015-0167-0.","journal-title":"J Exp Clin Cancer Res"},{"key":"16217_CR30","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13046-020-01550-w","volume":"39","author":"M Spagnuolo","year":"2020","unstructured":"Spagnuolo M, Costantini M, Ferriero M, Varmi M, Sperduti I, Regazzo G, et al. Urinary expression of let-7c cluster as non-invasive tool to assess the risk of disease progression in patients with high grade non-muscle invasive bladder Cancer: a pilot study. J Exp Clin Cancer Res. 2020;39:68. https:\/\/doi.org\/10.1186\/s13046-020-01550-w.","journal-title":"J Exp Clin Cancer Res"},{"key":"16217_CR31","doi-asserted-by":"publisher","first-page":"2970","DOI":"10.3390\/math9222970","volume":"9","author":"AM Rahmani","year":"2021","unstructured":"Rahmani AM, Yousefpoor E, Yousefpoor MS, Mehmood Z, Haider A, Hosseinzadeh M, et al. Machine Learning (ML) in Medicine: Review, Applications, and Challenges. Mathematics. 2021;9:2970. https:\/\/doi.org\/10.3390\/math9222970.","journal-title":"Mathematics"},{"key":"16217_CR32","doi-asserted-by":"publisher","first-page":"4178","DOI":"10.3390\/s23094178","volume":"23","author":"Q An","year":"2023","unstructured":"An Q, Rahman S, Zhou J, Kang JJ. A Comprehensive Review on Machine Learning in Healthcare Industry: Classification, Restrictions, Opportunities and Challenges. Sensors. 2023;23:4178. https:\/\/doi.org\/10.3390\/s23094178.","journal-title":"Sensors"},{"key":"16217_CR33","doi-asserted-by":"publisher","unstructured":"Pathak AK, Dewangan BK, Gupta M. Predicting Cardiovascular Diseases Using Machine Learning. Data Model Anal Internet Med Things. 1st ed. Boca Raton: CRC; 2023 [cited 2025 Sept 17]. pp. 109\u201325. https:\/\/doi.org\/10.1201\/9781003359951-9","DOI":"10.1201\/9781003359951-9"},{"key":"16217_CR34","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nrg3920","volume":"16","author":"MW Libbrecht","year":"2015","unstructured":"Libbrecht MW, Noble WS. Machine learning applications in genetics and genomics. Nat Rev Genet. 2015;16:321\u201332. https:\/\/doi.org\/10.1038\/nrg3920.","journal-title":"Nat Rev Genet"},{"key":"16217_CR35","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.csbj.2014.11.005","volume":"13","author":"K Kourou","year":"2015","unstructured":"Kourou K, Exarchos TP, Exarchos KP, Karamouzis MV, Fotiadis DI. Machine learning applications in cancer prognosis and prediction. Comput Struct Biotechnol J. 2015;13:8\u201317. https:\/\/doi.org\/10.1016\/j.csbj.2014.11.005.","journal-title":"Comput Struct Biotechnol J"},{"key":"16217_CR36","doi-asserted-by":"publisher","first-page":"30477","DOI":"10.1038\/s41598-025-99754-7","volume":"15","author":"S Singh","year":"2025","unstructured":"Singh S, Pathak AK, Kural S, Kumar L, Bhardwaj MG, Yadav M, et al. Integrating miRNA profiling and machine learning for improved prostate cancer diagnosis. Sci Rep. 2025;15:30477. https:\/\/doi.org\/10.1038\/s41598-025-99754-7.","journal-title":"Sci Rep"},{"key":"16217_CR37","doi-asserted-by":"publisher","first-page":"133","DOI":"10.22271\/maths.2023.v8.i6b.1463","volume":"8","author":"P Anandhi","year":"2023","unstructured":"Anandhi P, Nathiya DE. Application of linear regression with their advantages, disadvantages, assumption and limitations. Int J Stat Appl Math. 2023;8:133\u20137. https:\/\/doi.org\/10.22271\/maths.2023.v8.i6b.1463.","journal-title":"Int J Stat Appl Math"},{"key":"16217_CR38","doi-asserted-by":"publisher","first-page":"541","DOI":"10.3390\/healthcare10030541","volume":"10","author":"MM Ahsan","year":"2022","unstructured":"Ahsan MM, Luna SA, Siddique Z. Machine-Learning-Based Disease Diagnosis: A Comprehensive Review. Healthc Basel Switz. 2022;10:541. https:\/\/doi.org\/10.3390\/healthcare10030541.","journal-title":"Healthc Basel Switz"},{"key":"16217_CR39","doi-asserted-by":"publisher","first-page":"e38186","DOI":"10.1097\/MD.0000000000038186","volume":"103","author":"S Huang","year":"2024","unstructured":"Huang S, Zhang X, Ni X, Chen L, Ruan F. Logistic regression analysis of the value of biomarkers, clinical symptoms, and imaging examinations in COVID-19 for SARS-CoV-2 nucleic acid detection. Med (Baltim). 2024;103:e38186. https:\/\/doi.org\/10.1097\/MD.0000000000038186.","journal-title":"Med (Baltim)"},{"key":"16217_CR40","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/iju.15338","volume":"31","author":"E Tomiyama","year":"2024","unstructured":"Tomiyama E, Fujita K, Hashimoto M, Uemura H, Nonomura N. Urinary markers for bladder cancer diagnosis: A review of current status and future challenges. Int J Urol. 2024;31:208\u201319. https:\/\/doi.org\/10.1111\/iju.15338.","journal-title":"Int J Urol"},{"key":"16217_CR41","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.urolonc.2024.03.006","volume":"42","author":"S Kural","year":"2024","unstructured":"Kural S, Jain G, Agarwal S, Das P, Kumar L. Urinary extracellular vesicles-encapsulated miRNA signatures: A new paradigm for urinary bladder cancer diagnosis and classification. Urol Oncol Semin Orig Investig. 2024;42:179\u201390. https:\/\/doi.org\/10.1016\/j.urolonc.2024.03.006.","journal-title":"Urol Oncol Semin Orig Investig"},{"key":"16217_CR42","doi-asserted-by":"publisher","unstructured":"Zhang D-Z, Lau K-M, Chan ESY, Wang G, Szeto C-C, Wong K et al. Cell-Free Urinary MicroRNA-99a and MicroRNA-125b Are Diagnostic Markers for the Non-Invasive Screening of Bladder Cancer. Dahiya R, editor. PLoS ONE. 2014;9:e100793. https:\/\/doi.org\/10.1371\/journal.pone.0100793","DOI":"10.1371\/journal.pone.0100793"},{"key":"16217_CR43","doi-asserted-by":"publisher","first-page":"492","DOI":"10.3390\/diagnostics15040492","volume":"15","author":"\u0112 Biti\u0146a-Barlote","year":"2025","unstructured":"Biti\u0146a-Barlote \u0112, B\u013ciz\u0146uks D, Sili\u0146a S, \u0160atcs M, Vjaters E, Lietuvietis V, et al. Liquid Biopsy Based Bladder Cancer Diagnostic by Machine Learning. Diagnostics. 2025;15:492. https:\/\/doi.org\/10.3390\/diagnostics15040492.","journal-title":"Diagnostics"},{"key":"16217_CR44","doi-asserted-by":"publisher","first-page":"D147","DOI":"10.1093\/nar\/gkae1072","volume":"53","author":"S Cui","year":"2025","unstructured":"Cui S, Yu S, Huang H-Y, Lin Y-C-D, Huang Y, Zhang B, et al. miRTarBase 2025: updates to the collection of experimentally validated microRNA\u2013target interactions. Nucleic Acids Res. 2025;53:D147\u201356. https:\/\/doi.org\/10.1093\/nar\/gkae1072.","journal-title":"Nucleic Acids Res"},{"key":"16217_CR45","doi-asserted-by":"publisher","first-page":"D140","DOI":"10.1093\/nar\/gkj112","volume":"34","author":"S Griffiths-Jones","year":"2006","unstructured":"Griffiths-Jones S, miRBase. microRNA sequences, targets and gene nomenclature. Nucleic Acids Res. 2006;34:D140\u20134. https:\/\/doi.org\/10.1093\/nar\/gkj112.","journal-title":"Nucleic Acids Res"},{"key":"16217_CR46","doi-asserted-by":"publisher","unstructured":"Chin C-H, Chen S-H, Wu H-H, Ho C-W, Ko M-T, Lin C-Y. cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol. 2014;8:S11. https:\/\/doi.org\/10.1186\/1752-0509-8-S4-S11","DOI":"10.1186\/1752-0509-8-S4-S11"},{"key":"16217_CR47","doi-asserted-by":"publisher","first-page":"4118","DOI":"10.3390\/math11194118","volume":"11","author":"D-H Shih","year":"2023","unstructured":"Shih D-H, Shih P-L, Wu T-W, Lee C-X, Shih M-H. Distinguishing Bladder Cancer from Cystitis Patients Using Deep Learning. Mathematics. 2023;11:4118. https:\/\/doi.org\/10.3390\/math11194118.","journal-title":"Mathematics"},{"key":"16217_CR48","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.urolonc.2012.07.001","volume":"32","author":"A Buteau","year":"2014","unstructured":"Buteau A, Seideman CA, Svatek RS, Youssef RF, Chakrabarti G, Reed G, et al. What is evaluation of hematuria by primary care physicians? Use of electronic medical records to assess practice patterns with intermediate follow-up. Urol Oncol Semin Orig Investig. 2014;32:128\u201334. https:\/\/doi.org\/10.1016\/j.urolonc.2012.07.001.","journal-title":"Urol Oncol Semin Orig Investig"},{"key":"16217_CR49","doi-asserted-by":"publisher","first-page":"703","DOI":"10.3390\/diagnostics10090703","volume":"10","author":"SJ Galgano","year":"2020","unstructured":"Galgano SJ, Porter KK, Burgan C, Rais-Bahrami S. The Role of Imaging in Bladder Cancer Diagnosis and Staging. Diagn Basel Switz. 2020;10:703. https:\/\/doi.org\/10.3390\/diagnostics10090703.","journal-title":"Diagn Basel Switz"},{"key":"16217_CR50","doi-asserted-by":"publisher","first-page":"840","DOI":"10.4103\/jfmpc.jfmpc_186_17","volume":"6","author":"MM Gharibvand","year":"2017","unstructured":"Gharibvand MM, Kazemi M, Motamedfar A, Sametzadeh M, Sahraeizadeh A. The role of ultrasound in diagnosis and evaluation of bladder tumors. J Fam Med Prim Care. 2017;6:840\u20133. https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_186_17.","journal-title":"J Fam Med Prim Care"},{"key":"16217_CR51","doi-asserted-by":"publisher","first-page":"66e25","DOI":"10.1016\/j.urolonc.2014.06.008","volume":"33","author":"FA Yafi","year":"2015","unstructured":"Yafi FA, Brimo F, Steinberg J, Aprikian AG, Tanguay S, Kassouf W. Prospective analysis of sensitivity and specificity of urinary cytology and other urinary biomarkers for bladder cancer. Urol Oncol Semin Orig Investig. 2015;33:66e25. https:\/\/doi.org\/10.1016\/j.urolonc.2014.06.008.","journal-title":"Urol Oncol Semin Orig Investig"},{"key":"16217_CR52","doi-asserted-by":"publisher","unstructured":"Wan X, Wang D, Zhang X, Xu M, Huang Y, Qin W, et al. Unleashing the power of urine\u2013based biomarkers in diagnosis, prognosis and monitoring of bladder cancer (Review). Int J Oncol [Internet]. 2025;66. https:\/\/doi.org\/10.3892\/ijo.2025.5724.","DOI":"10.3892\/ijo.2025.5724"},{"key":"16217_CR53","doi-asserted-by":"publisher","first-page":"100296","DOI":"10.1016\/j.jlb.2025.100296","volume":"8","author":"AG Cicatiello","year":"2025","unstructured":"Cicatiello AG, Musone M, Imperatore S, Giulioni C, La Rocca R, Cafarelli A, et al. Circulating miRNAs in genitourinary cancer: pioneering advances in early detection and diagnosis. J Liq Biopsy. 2025;8:100296. https:\/\/doi.org\/10.1016\/j.jlb.2025.100296.","journal-title":"J Liq Biopsy"},{"key":"16217_CR54","doi-asserted-by":"publisher","first-page":"18774","DOI":"10.1038\/s41598-024-66770-y","volume":"14","author":"AK Pathak","year":"2024","unstructured":"Pathak AK, Kural S, Singh S, Kumar L, Yadav M, Gupta M, et al. Development of a robust and generalizable algorithm gQuant for accurate normalizer gene selection in qRT-PCR analysis. Sci Rep. 2024;14:18774. https:\/\/doi.org\/10.1038\/s41598-024-66770-y.","journal-title":"Sci Rep"},{"key":"16217_CR55","doi-asserted-by":"publisher","unstructured":"Pathak A, Kural S, Singh S, Kumar L, Gupta M, Jain G. Analysis of qRT-PCR Data to Identify the Most Stable Reference Gene Using gQuant. BIO-Protoc. 2025 [cited 2025 Sept 18];15. https:\/\/doi.org\/10.21769\/BioProtoc.5292","DOI":"10.21769\/BioProtoc.5292"},{"key":"16217_CR56","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1158\/0008-5472.CAN-14-1041","volume":"75","author":"ST Bailey","year":"2015","unstructured":"Bailey ST, Westerling T, Brown M. Loss of Estrogen-Regulated microRNA Expression Increases HER2 Signaling and Is Prognostic of Poor Outcome in Luminal Breast Cancer. Cancer Res. 2015;75:436\u201345. https:\/\/doi.org\/10.1158\/0008-5472.CAN-14-1041.","journal-title":"Cancer Res"},{"key":"16217_CR57","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.clcc.2013.11.006","volume":"13","author":"F Cappuzzo","year":"2014","unstructured":"Cappuzzo F, Sacconi A, Landi L, Ludovini V, Biagioni F, D\u2019Incecco A, et al. MicroRNA Signature in Metastatic Colorectal Cancer Patients Treated With Anti-EGFR Monoclonal Antibodies. Clin Colorectal Cancer. 2014;13:37\u2013e454. https:\/\/doi.org\/10.1016\/j.clcc.2013.11.006.","journal-title":"Clin Colorectal Cancer"},{"key":"16217_CR58","doi-asserted-by":"publisher","first-page":"3376","DOI":"10.1038\/onc.2015.396","volume":"35","author":"K-Y Lin","year":"2016","unstructured":"Lin K-Y, Ye H, Han B-W, Wang W-T, Wei P-P, He B, et al. Genome-wide screen identified let-7c\/miR-99a\/miR-125b regulating tumor progression and stem-like properties in cholangiocarcinoma. Oncogene. 2016;35:3376\u201386. https:\/\/doi.org\/10.1038\/onc.2015.396.","journal-title":"Oncogene"},{"key":"16217_CR59","doi-asserted-by":"publisher","unstructured":"Hofbauer SL, De Martino M, Lucca I, Haitel A, Susani M, Shariat SF, et al. A urinary microRNA (miR) signature for diagnosis of bladder cancer. Urol Oncol Semin Orig Investig. 2018;36. https:\/\/doi.org\/10.1016\/j.urolonc.2018.09.006. :531.e1-531.e8.","DOI":"10.1016\/j.urolonc.2018.09.006"},{"key":"16217_CR60","doi-asserted-by":"publisher","first-page":"20658","DOI":"10.18632\/oncotarget.25057","volume":"9","author":"B Pardini","year":"2018","unstructured":"Pardini B, Cordero F, Naccarati A, Viberti C, Birolo G, Oderda M, et al. microRNA profiles in urine by next-generation sequencing can stratify bladder cancer subtypes. Oncotarget. 2018;9:20658\u201369. https:\/\/doi.org\/10.18632\/oncotarget.25057.","journal-title":"Oncotarget"},{"key":"16217_CR61","doi-asserted-by":"publisher","first-page":"694","DOI":"10.5114\/aoms.2019.89700","volume":"19","author":"EM Borkowska","year":"2023","unstructured":"Borkowska EM, Kutwin P, Rolecka D, Konecki T, Borowiec M, Jab\u0142onowski Z. Clinical value of microRNA-19a-3p and microRNA-99a-5p in bladder cancer. Arch Med Sci AMS. 2023;19:694\u2013702. https:\/\/doi.org\/10.5114\/aoms.2019.89700.","journal-title":"Arch Med Sci AMS"},{"key":"16217_CR62","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/1471-2490-14-50","volume":"14","author":"Y Feng","year":"2014","unstructured":"Feng Y, Kang Y, He Y, Liu J, Liang B, Yang P, et al. microRNA-99a acts as a tumor suppressor and is down-regulated in bladder cancer. BMC Urol. 2014;14:50. https:\/\/doi.org\/10.1186\/1471-2490-14-50.","journal-title":"BMC Urol"},{"key":"16217_CR63","doi-asserted-by":"publisher","first-page":"19330","DOI":"10.1002\/jcb.27318","volume":"120","author":"Y Liu","year":"2019","unstructured":"Liu Y, Li B, Yang X, Zhang C. MiR-99a\u20105p inhibits bladder cancer cell proliferation by directly targeting mammalian target of rapamycin and predicts patient survival. J Cell Biochem. 2019;120:19330\u20137. https:\/\/doi.org\/10.1002\/jcb.27318.","journal-title":"J Cell Biochem"},{"key":"16217_CR64","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1002\/ijc.25509","volume":"128","author":"L Huang","year":"2011","unstructured":"Huang L, Luo J, Cai Q, Pan Q, Zeng H, Guo Z, et al. MicroRNA-125b suppresses the development of bladder cancer by targeting E2F3. Int J Cancer. 2011;128:1758\u201369. https:\/\/doi.org\/10.1002\/ijc.25509.","journal-title":"Int J Cancer"},{"key":"16217_CR65","doi-asserted-by":"publisher","first-page":"58642","DOI":"10.18632\/oncotarget.17407","volume":"8","author":"C Avellini","year":"2017","unstructured":"Avellini C, Licini C, Lazzarini R, Gesuita R, Guerra E, Tossetta G, et al. The trophoblast cell surface antigen 2 and miR-125b axis in urothelial bladder cancer. Oncotarget. 2017;8:58642\u201353. https:\/\/doi.org\/10.18632\/oncotarget.17407.","journal-title":"Oncotarget"},{"key":"16217_CR66","first-page":"2346","volume":"7","author":"X Zhao","year":"2015","unstructured":"Zhao X, He W, Li J, Huang S, Wan X, Luo H, et al. MiRNA-125b inhibits proliferation and migration by targeting SphK1 in bladder cancer. Am J Transl Res. 2015;7:2346\u201354.","journal-title":"Am J Transl Res"},{"key":"16217_CR67","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s13577-019-00285-x","volume":"33","author":"S Liu","year":"2020","unstructured":"Liu S, Chen Q, Wang Y. MiR-125b-5p suppresses the bladder cancer progression via targeting HK2 and suppressing PI3K\/AKT pathway. Hum Cell. 2020;33:185\u201394. https:\/\/doi.org\/10.1007\/s13577-019-00285-x.","journal-title":"Hum Cell"},{"key":"16217_CR68","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.3892\/ol.2014.1875","volume":"7","author":"D Wu","year":"2014","unstructured":"Wu D, Zhou Y, Pan H, Zhou J, Fan Y, Qu P. microRNA-99a inhibiting cell proliferation, migration and invasion by targeting fibroblast growth factor receptor 3 in bladder cancer. Oncol Lett. 2014;7:1219\u201324. https:\/\/doi.org\/10.3892\/ol.2014.1875.","journal-title":"Oncol Lett"},{"key":"16217_CR69","doi-asserted-by":"publisher","first-page":"6375","DOI":"10.18632\/oncotarget.2221","volume":"5","author":"RM Drayton","year":"2014","unstructured":"Drayton RM, Peter S, Myers K, Miah S, Dudziec E, Bryant HE, et al. MicroRNA-99a and 100 mediated upregulation of FOXA1 in bladder cancer. Oncotarget. 2014;5:6375\u201386. https:\/\/doi.org\/10.18632\/oncotarget.2221.","journal-title":"Oncotarget"},{"key":"16217_CR70","doi-asserted-by":"publisher","first-page":"100310","DOI":"10.1016\/j.jlb.2025.100310","volume":"9","author":"F Crocetto","year":"2025","unstructured":"Crocetto F, Amicuzi U, Musone M, Magliocchetti M, Di Lieto D, Tammaro S, et al. Liquid Biopsy: Current advancements in clinical practice for bladder cancer. J Liq Biopsy. 2025;9:100310. https:\/\/doi.org\/10.1016\/j.jlb.2025.100310.","journal-title":"J Liq Biopsy"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16217-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16217-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16217-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:02:48Z","timestamp":1792422168000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16217-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,21]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["16217"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-16217-6","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,21]]},"assertion":[{"value":"24 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Institutional Ethics Committee (EC\/3411) at the Institute of Medical Sciences, Banaras Hindu University (IMS BHU) and written informed consent was obtained from all participants involved in the study. The study was conducted in accordance with the Declaration of Helsinki and relevant institutional guidelines.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not Applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1258"}}